Amplia Therapeutics (ASX:ATX) has announced the immediate suspension of trading for its options under the code ATXOA. This suspension is due to the absence of deferred settlement trading and was enacted under ASX Listing Rule 17.3. It is important to note that this suspension does not affect the trading of the company's other securities.
Amplia Therapeutics has had its ATXOA options suspended from trading by the ASX due to the absence of deferred settlement trading. This procedural action, effective immediately, ensures compliance with ASX Listing Rule 17.3. The suspension is specific to these options and does not impact other securities of the company. Amplia Therapeutics remains committed to maintaining transparency and compliance with ASX regulations. The company assures its stakeholders that the overall trading activities of its stock remain unaffected. For further inquiries, the ASX Customer Service Centre is available to assist.
The suspension affects only ATXOA options and not other securities of Amplia Therapeutics Limited quoted on the exchange.